“…Traditionally, ChIP-seq protocols have required relatively large amounts of sample (~10 million cells), limiting their application to the study of readily available tissue (Huang et al, 2006) (Furey, 2012). In addition, these approaches have traditionally employed tissue homogenates, thereby failing, by necessity, to address the cellular diversity found in the brain (Mitchell et al, 2014a). However, an increasing number of new methods have become available that are compatible with low-input (Adli and Bernstein, 2011; Brind’Amour et al, 2015; Jakobsen et al, 2015; Lara-Astiaso et al, 2014; Ng et al, 2013; Schmidl et al, 2015; Shankaranarayanan et al, 2011; Zwart et al, 2013).…”